Christina Peters Selected Research

Osteopetrosis

4/2012

Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christina Peters Research Topics

Disease

27	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 05/2003
15	Neoplasms (Cancer) 01/2022 - 02/2007
14	Leukemia 01/2022 - 01/2005
8	Infections 01/2021 - 08/2003
7	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 10/2005
7	Residual Neoplasm 01/2021 - 01/2009
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 12/2013
5	Bronchiolitis Obliterans Syndrome 01/2018 - 10/2005
4	Virus Diseases (Viral Diseases) 01/2021 - 10/2005
4	Aplastic Anemia (Anemia, Hypoplastic) 05/2015 - 11/2013
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2016
2	beta-Thalassemia (Cooley's Anemia) 03/2022 - 05/2014
2	Mycoses (Diseases, Fungus) 01/2021 - 01/2017
2	Communicable Diseases (Infectious Diseases) 06/2020 - 01/2020
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2020 - 04/2012
2	Hematologic Diseases (Blood Diseases) 01/2020 - 01/2020
2	Neutropenia 01/2017 - 03/2009
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2014 - 12/2013
2	Sickle Cell Anemia (Hemoglobin S Disease) 05/2014 - 04/2013
2	Juvenile Myelomonocytic Leukemia 09/2013 - 01/2005
2	Disease Progression 08/2012 - 08/2011
1	Necrosis 01/2022
1	Hemolysis 01/2021
1	Fever (Fevers) 01/2021
1	Pure Red-Cell Aplasia 01/2021
1	Pathologic Complete Response 01/2021
1	COVID-19 01/2021
1	Viremia 01/2021
1	Mucositis 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Iron Overload 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Vomiting 01/2020
1	Bacteremia 01/2019
1	Osteonecrosis (Kienbock's Disease) 10/2018
1	Cytokine Release Syndrome 01/2018
1	Thalassemia 01/2018
1	Febrile Neutropenia 01/2017
1	Sepsis (Septicemia) 01/2017
1	Lymphoma (Lymphomas) 01/2016
1	Autosomal Recessive 3 Severe Congenital Neutropenia 10/2015
1	idiopathic Aplastic anemia 10/2014
1	Typical Teratoid Rhabdoid Tumor 02/2014
1	Fanconi Anemia (Fanconi's Anemia) 12/2013
1	Cytopenia 04/2013
1	Pneumonia (Pneumonitis) 10/2012
1	Food Hypersensitivity (Food Allergy) 10/2012
1	Exanthema (Rash) 10/2012
1	Eosinophilia 10/2012
1	Atopic Dermatitis (Atopic Eczema) 10/2012
1	Respiratory Tract Infections (Respiratory Tract Infection) 08/2012
1	Osteopetrosis 04/2012

Drug/Important Bio-Agent (IBA)

4	Busulfan (Busulfex)FDA Link 03/2022 - 01/2016
3	fludarabineIBA 03/2022 - 12/2013
3	treosulfanIBA 03/2022 - 01/2016
3	SteroidsIBA 09/2013 - 08/2011
2	blinatumomabIBA 01/2021 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2019
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020 - 09/2013
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 10/2005 - 10/2005
1	TransferasesIBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA 01/2022
1	Hemagglutinins (Hemagglutinin)IBA 01/2021
1	AntigensIBA 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	ProcalcitoninIBA 01/2021
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	tisagenlecleucelIBA 01/2018
1	tocilizumab (atlizumab)FDA Link 01/2018
1	Chimeric Antigen ReceptorsIBA 01/2018
1	Vancomycin FDA LinkGeneric 01/2017
1	TeicoplaninIBA 01/2017
1	Ado-Trastuzumab EmtansineIBA 06/2015
1	Immunoconjugates (Immunoconjugate)IBA 06/2015
1	Cytotoxins (Cytolysins)IBA 06/2015
1	Brentuximab VedotinIBA 06/2015
1	Blood Group Antigens (Blood Groups)IBA 05/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2013
1	Immunoglobulin E (IgE)IBA 10/2012
1	Proteins (Proteins, Gene)FDA Link 10/2012
1	defibrotideIBA 04/2012

Therapy/Procedure

45	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2005
22	Transplantation 11/2019 - 01/2005
19	Stem Cell Transplantation 01/2021 - 05/2003
14	Drug Therapy (Chemotherapy) 01/2021 - 05/2003
10	Therapeutics 01/2020 - 01/2005
2	Cell Transplantation 01/2020 - 11/2019
2	Homologous Transplantation 04/2015 - 06/2008
1	Donor Selection 01/2021
1	Consolidation Chemotherapy 01/2021
1	Parenteral Nutrition 01/2020
1	Antibiotic Prophylaxis 01/2017
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2015
1	Aftercare (After-Treatment) 09/2014
1	Radiotherapy 02/2014
1	Isogeneic Transplantation 11/2013